JW JoongWoe Pharmaceutical, 4.4 Billion KRW Paid-in Capital Increase
[Asia Economy Reporter Kwon Jaehee] JW Pharmaceutical announced on the 20th that it will conduct a third-party allotment paid-in capital increase worth 4.4 billion KRW for operating funds. The issue price per new share is 30,871 KRW.
Hot Picks Today
"Samsung and Hynix Were Once for the Underachievers"... Hyundai Motor Employee's Lament
- "Was This Delicious Treat Enjoyed Only by Koreans?"... The K-Dessert Captivating Japan
- "Iran Considers Usage Fees From Surface to Seabed, Eyes $15 Billion Annual Revenue"
- Fair Trade Commission Fines "Big Five" Couriers Including Coupang and CJ 3 Billion Won for Shifting Safety Accident Liability to Agencies
- "That? It's Already Stashed" Nightlife Scene Crosses the Line [ChwiYak Nation] ③
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
